PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 158 filers reported holding PDL BIOPHARMA INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $1,000 | -99.9% | 596 | -99.7% | 0.00% | – |
| Q3 2020 | $737,000 | +2.4% | 234,302 | -5.5% | 0.00% | -100.0% |
| Q2 2020 | $720,000 | +15.6% | 247,924 | +12.3% | 0.00% | – |
| Q1 2020 | $623,000 | +67.5% | 220,721 | +92.1% | 0.00% | – |
| Q4 2019 | $372,000 | -36.7% | 114,927 | -57.8% | 0.00% | – |
| Q3 2019 | $588,000 | -1.7% | 272,399 | +43.3% | 0.00% | – |
| Q2 2019 | $598,000 | +19.6% | 190,094 | +41.7% | 0.00% | – |
| Q1 2019 | $500,000 | +55.8% | 134,190 | +21.4% | 0.00% | – |
| Q4 2018 | $321,000 | -70.4% | 110,541 | -73.2% | 0.00% | -100.0% |
| Q3 2018 | $1,085,000 | +287.5% | 413,069 | +244.2% | 0.00% | – |
| Q2 2018 | $280,000 | +38.6% | 119,998 | +74.6% | 0.00% | – |
| Q1 2018 | $202,000 | +20.2% | 68,745 | +11.8% | 0.00% | – |
| Q4 2017 | $168,000 | +57.0% | 61,499 | +95.2% | 0.00% | – |
| Q3 2017 | $107,000 | +174.4% | 31,499 | +97.3% | 0.00% | – |
| Q2 2017 | $39,000 | -71.5% | 15,968 | -73.3% | 0.00% | – |
| Q1 2017 | $137,000 | -46.5% | 59,856 | -50.4% | 0.00% | – |
| Q4 2016 | $256,000 | +153.5% | 120,744 | +298.2% | 0.00% | – |
| Q3 2016 | $101,000 | -76.1% | 30,326 | -77.4% | 0.00% | – |
| Q2 2016 | $422,000 | -43.8% | 134,249 | -46.3% | 0.00% | – |
| Q1 2016 | $751,000 | +301.6% | 250,183 | +304.6% | 0.00% | – |
| Q4 2015 | $187,000 | -80.0% | 61,832 | -66.9% | 0.00% | -100.0% |
| Q3 2015 | $936,000 | -20.3% | 186,992 | -4.5% | 0.00% | 0.0% |
| Q2 2015 | $1,174,000 | -17.7% | 195,785 | -4.1% | 0.00% | 0.0% |
| Q1 2015 | $1,427,000 | -13.4% | 204,149 | -13.2% | 0.00% | 0.0% |
| Q4 2014 | $1,647,000 | +1.7% | 235,187 | +1.6% | 0.00% | 0.0% |
| Q3 2014 | $1,620,000 | -42.9% | 231,520 | -26.6% | 0.00% | -66.7% |
| Q2 2014 | $2,839,000 | -28.1% | 315,564 | -36.1% | 0.00% | -25.0% |
| Q1 2014 | $3,950,000 | -12.9% | 493,861 | -12.9% | 0.00% | 0.0% |
| Q4 2013 | $4,537,000 | +51.9% | 566,985 | +32.9% | 0.00% | +33.3% |
| Q3 2013 | $2,987,000 | +61.5% | 426,636 | +78.2% | 0.00% | 0.0% |
| Q2 2013 | $1,849,000 | – | 239,476 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nine Chapters Capital Management LLC | 119,700 | $254,000 | 0.43% |
| GSA CAPITAL PARTNERS LLP | 1,587,756 | $3,366,000 | 0.20% |
| AMERICAFIRST CAPITAL MANAGEMENT, LLC | 60,901 | $129,110,000 | 0.14% |
| Acrospire Investment Management LLC | 129,480 | $274,000 | 0.11% |
| SECOR Capital Advisors, LP | 410,323 | $870,000 | 0.11% |
| RBF Capital, LLC | 251,421 | $540,000 | 0.08% |
| Park West Asset Management LLC | 400,000 | $848,000 | 0.07% |
| MACKENZIE FINANCIAL CORP | 4,687,825 | $9,938,000 | 0.06% |
| CIGNA INVESTMENTS INC /NEW | 261,533 | $554,000,000 | 0.06% |
| ACADIAN ASSET MANAGEMENT LLC | 5,503,285 | $11,665,000 | 0.06% |